StockWatch
·

Research Reports

29 Oct 2026
LALPATHLABDr. Lal PathLabs Ltd

Can Dr. Lal PathLabs sustain Q1's 19% growth as it scales acquisitions?

diagnostics · revenue growth · margin expansion

Result previewQ2 FY273 minPharma & Healthcare
KIMSKrishna Institute of Medical Sciences Ltd

New Units Ramping — Can Momentum Offset Margin Pressure?

healthcare · hospital expansion · margin pressure

Result previewQ2 FY273 minPharma & Healthcare
WOCKPHARMAWOCKHARDT LTD.

Turnaround Holds — Profitability Momentum into Q2 on Watch

pharma · turnaround · Q2 FY27

Result previewQ2 FY273 minPharma & Healthcare
28 Oct 2026
SANOFICONRSanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare: Q2 FY27 PAT +22% YoY, margins expand on domestic growth

consumer healthcare · pharma · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
FDCFDC LTD.

FDC pairs a ₹120 Cr buyback at ₹500 — 41% above the pre-announcement close — with a 73% jump in Q2 profit

FDC · buyback · tender offer

Research4 minPharma & Healthcare
PFIZERPFIZER LTD.

Mid-cycle momentum on track, but Minipress discontinuation casts shadow

pharma earnings · revenue growth · minipress discontinuation

Result previewQ2 FY273 minPharma & Healthcare
NEULANDLABNEULAND LABORATORIES LTD.

CDMO Expansion Test: Can Neuland Hold Margins in a Growth Year?

CDMO · peptide-expansion · FDA-approval

Result previewQ2 FY273 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

Emcure expects to sustain export momentum—watch for margin trajectory amid higher international mix

export growth · margin trajectory · Gennova integration

Result previewQ2 FY273 minPharma & Healthcare
NHNarayana Hrudayalaya Ltd

Sustaining Q1's momentum: execution and new-bed ramp in focus

Result previewQ2 FY273 minPharma & Healthcare
MEDANTAGlobal Health Ltd

Revenue momentum on test as Medanta scales network

hospital expansion · revenue growth · ARPOB

Result previewQ2 FY273 minPharma & Healthcare
GLAXOGLAXOSMITHKLINE PHARMACEUTICALS LTD.

Innovation Momentum Under Test: Can GSK Scale New Portfolios Without Margin Bleed?

pharma earnings · innovation portfolio · margin pressure

Result previewQ2 FY273 minPharma & Healthcare
LUPINLUPIN LTD.

Can Lupin sustain Q1's US momentum into Q2?

US generics · margin expansion · India growth

Result previewQ2 FY273 minPharma & Healthcare
27 Oct 2026
PPLPHARMAPiramal Pharma Ltd

Piramal Pharma turns profitable; consolidated PAT ₹5.6 Cr as OPM expands to 13.3%

pharma cdmo · margin expansion · turnaround

ResultsQ2 FY273 minPharma & Healthcare
SYNGENESyngene International Ltd

Syngene Q2 FY27: PAT -52% YoY to ₹32 Cr as margin rebounds off Q1's low

crdmo · biologics contract loss · margin recovery

ResultsQ2 FY273 minPharma & Healthcare
CONCORDBIOConcord Biotech Ltd

Concord Biotech Q2 (consol): PAT +10% YoY trails 25% revenue growth as margins compress

pharmaceutical apis · injectable facility ramp · margin compression

ResultsQ2 FY273 minPharma & Healthcare
FDCFDC LTD.

FDC Q2 FY27: consolidated PAT +73% YoY to ₹49 Cr on margin expand; QoQ fall is seasonal

pharmaceuticals · margin expansion · share buyback

ResultsQ2 FY273 minPharma & Healthcare
BAJAJHCAREBajaj Healthcare Ltd

Beat Guidance, But API Softness and Capex Doubling Are the Real Reads

API pricing pressure · peptide CDMO · Genrx acquisition

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
BAJAJHCAREBajaj Healthcare Ltd

Strong growth beats guidance, but API pricing remains soft

peptide manufacturing · Genrx acquisition · Cenobamate launch

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
MOREPENLABMOREPEN LABORATORIES LTD.

Morepen Labs Q2 FY27: consol PAT +117% YoY to ₹88.9 Cr, CDMO ramp drives margin expansion

cdmo ramp · margin expansion · pharmaceutical exports

ResultsQ2 FY273 minPharma & Healthcare
ACUTAASAmi Organics Ltd

Acutaas Chemicals' Q2 FY27 consolidated PAT jumps 71% YoY as margins expand to ~40%

specialty chemicals · pharma intermediates · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
CIPLACIPLA LTD.

Cipla Q2FY27: consolidated PAT falls 37% YoY on margin squeeze, back in guidance band

pharma · margin compression · ebitda guidance

ResultsQ2 FY273 minPharma & Healthcare
ONESOURCEOnesource Specialty Pharma Ltd

OneSource Q2 FY27: consol. PAT leaps 448% YoY to ₹57.5 Cr, NPM triples to 11.1%

cdmo · semaglutide · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
MOREPENLABMOREPEN LABORATORIES LTD.

CDMO Momentum in Focus as Q2 FY27 Earnings Loom

CDMO growth · pharma margins · API expansion

Result previewQ2 FY273 minPharma & Healthcare
SPARCSUN PHARMA ADVANCED RESEARCH COMPANY LTD.

Loss Narrowing Under Scrutiny—Can SPARC Sustain Momentum Without One-Offs?

SPARC · Q2 FY27 · loss narrowing

Result previewQ2 FY273 minPharma & Healthcare
BLISSGVSBLISS GVS PHARMA LTD.

First Quarter Under New Ownership: Execution and Margin Resilience in Focus

change of control · formulations · Anupam Rasayan

Result previewQ2 FY273 minPharma & Healthcare
MEDPLUSMedplus Health Services Ltd

Margin recovery in focus as Medplus chases growth

operating margin · pharmacy retail · store expansion

Result previewQ2 FY273 minPharma & Healthcare
PGHLProcter & Gamble Health Ltd

Can PGHL Arrest Growth Slowdown Amid Raw Material Headwinds?

margin pressure · raw material costs · growth deceleration

Result previewQ2 FY273 minPharma & Healthcare
GRANULESGRANULES INDIA LTD.-$

Granules Eyes Double-Digit Growth as Transformation Gains Traction

Result previewQ2 FY273 minPharma & Healthcare
26 Oct 2026
TLLTrident Lifeline Ltd

Trident Lifeline Q2 FY27: consolidated revenue +50% YoY, PAT +33%, margin compresses

pharma manufacturing · subsidiary consolidation · margin compression

ResultsQ2 FY273 minPharma & Healthcare
VENUSREMVENUS REMEDIES LTD.

Venus Remedies Q2 FY27: PAT +27% YoY to ₹25.65 Cr, margins expand, revenue beats Street

pharmaceuticals · margin expansion · international registrations

ResultsQ2 FY273 minPharma & Healthcare